Form 8-K - Current report:
SEC Accession No. 0000950103-24-016317
Filing Date
2024-11-14
Accepted
2024-11-14 16:47:15
Documents
16
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp220702_8k.htm   iXBRL 8-K 23687
2 EXHIBIT 99.1 dp220702_ex9901.htm EX-99.1 85368
3 GRAPHIC image_002.jpg GRAPHIC 1803
4 GRAPHIC image_003.jpg GRAPHIC 1803
  Complete submission text file 0000950103-24-016317.txt   298562

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pgen-20241114.xsd EX-101.SCH 3000
6 XBRL LABEL FILE pgen-20241114_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE pgen-20241114_pre.xml EX-101.PRE 22349
18 EXTRACTED XBRL INSTANCE DOCUMENT dp220702_8k_htm.xml XML 3552
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 241463679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)